Pharmabiz5m
AstraZeneca’s AZD0780, a novel oral PCSK9 inhibitor, demonstrates significant LDL cholesterol reduction in PURSUIT phase IIb trial
AstraZeneca’s AZD0780, a novel oral PCSK9 inhibitor, demonstrates significant LDL cholesterol reduction in PURSUIT phase IIb trial: Cambridge, UK Wednesday, April 2, 2025, 11:00 ...
Pharmabiz1h
Zimmer Biomet RibFix Advantage Fixation System receives CE Mark certificationr
Zimmer Biomet RibFix Advantage Fixation System receives CE Mark certificationr: Warsaw, Indiana Wednesday, April 2, 2025, 10:00 Hrs [IST] Zimmer Biomet Holdings, Inc., a global me ...
Pharmabiz2h
Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease
Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...
Pharmabiz3h
Guidelines issued by Odisha DI are provisions of D&C Act, companies cannot fully comply with it: Ex TN DC
Peethaambaran Kunnathoor, Chennai Wednesday, April 2, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
Gujarat FDCA to strengthen drug quality control with procurement of 25 advanced handheld spectrophotometers
Gujarat FDCA to strengthen drug quality control with procurement of 25 advanced handheld spectrophotometers: Shardul Nautiyal, Mumbai Wednesday, April 2, 2025, 08:00 Hrs [IST] In ...
Pharmabiz3h
Panel asks DoP to prepare comprehensive action plan to enhance infrastructure in seven existing NIPERs
Panel asks DoP to prepare comprehensive action plan to enhance infrastructure in seven existing NIPERs: Gireesh Babu, New Delhi Wednesday, April 2, 2025, 08:00 Hrs [IST] Raising c ...
Pharmabiz3h
Dr Sanjay Agrawal applies for patent for a specialized formulation for CKD related nutritional deficiencies
Dr Sanjay Agrawal applies for patent for a specialized formulation for CKD related nutritional deficiencies: Shardul Nautiyal, Mumbai Wednesday, April 2, 2025, 08:00 Hrs [IST] Dr ...
Pharmabiz3h
Karnataka & Netherlands accelerate pace of AI driven healthtech implementation across govt hospitals
Karnataka & Netherlands accelerate pace of AI driven healthtech implementation across govt hospitals: Nandita Vijayasimha, Bengaluru Wednesday, April 2, 2025, 08:00 Hrs [IST] Karn ...
Pharmabiz17h
Novo Nordisk presents positive results from SOUL cardiovascular outcomes trial of Rybelsus at ACC’s annual scientific session
Bagsværd, Denmark Tuesday, April 1, 2025, 18:00 Hrs [IST] ...
Pharmabiz18h
EMA committee recommends approval of AstraZeneca’s Calquence plus chemoimmunotherapy to treat adult patients with mantle cell lymphoma
EMA committee recommends approval of AstraZeneca’s Calquence plus chemoimmunotherapy to treat adult patients with mantle cell lymphoma: Cambridge, UK Tuesday, April 1, 2025, 17: ...
Pharmabiz18h
Akums launches novel ripasudil+timolol combination for glaucoma and ocular hypertension
Akums launches novel ripasudil+timolol combination for glaucoma and ocular hypertension: Our Bureau, Bengaluru Tuesday, April 1, 2025, 16:40 Hrs [IST] Akums Drugs & Pharmaceutical ...
Pharmabiz18h
Strides Pharma recognized in S&P Global Sustainability Yearbook 2025
Strides Pharma recognized in S&P Global Sustainability Yearbook 2025: Our Bureau, Bengaluru Tuesday, April 1, 2025, 16:30 Hrs [IST] Strides Pharma Science has been recognized in t ...